Caverject 20.5 ug/mL
Alprostadil · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Pharmacia & Upjohn Company LLC
No Recall History
Plain English
Caverject is a injection, powder, lyophilized, for solution containing alprostadil at 20.5 ug/mL, taken intracavernous. Manufactured by Pharmacia & Upjohn Company LLC.
Key Facts
- Brand Name
- Caverject
- Generic Name
- Alprostadil
- NDC Code (Product)
0009-3701- Manufacturer
- Pharmacia & Upjohn Company LLC
- Strength
- 20.5 ug/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRACAVERNOUS
- Marketing Status
- Application #
- NDA020379
- Drug Class
- Prostaglandin Analog [EPC]; Prostaglandin E1 Agonist [EPC]
- Marketing Start
- 07/06/1995
Recall History
No Recall HistoryFrequently Asked Questions
What is Caverject used for?
Caverject contains Alprostadil. It is a injection, powder, lyophilized, for solution taken intracavernous. Consult your doctor for specific uses.
Is Caverject a controlled substance?
Caverject is not classified as a controlled substance by the DEA.
What is the generic name for Caverject?
The generic name for Caverject is Alprostadil. There are 8 other brand versions of Alprostadil.
What is the NDC code for Caverject 20.5 ug/mL?
The NDC (National Drug Code) for Caverject 20.5 ug/mL is 0009-3701, listed by Pharmacia & Upjohn Company LLC.